| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $1.56B | +4.3% |
| Cost of Revenue | $191.4M | -3.0% |
| R&D Expense | $96.7M | +6.3% |
| SG&A Expense | $211.1M | +3.4% |
| Operating Income | $1.06B | +5.8% |
| Interest Expense | $75.3M | +0.0% |
| Pre-tax Income | $1.02B | +4.6% |
| Income Tax | $236.2M | +48.6% |
| Net Income | $785.7M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $206.7M | -13.9% |
| Short-term Investments | $393.2M | -42.7% |
| Accounts Receivable | $5.6M | -11.1% |
| Current Assets | $663.8M | -32.8% |
| Total Assets | $1.41B | -19.6% |
| Current Liabilities | $1.53B | +28.8% |
| Total Liabilities | $3.36B | +1.0% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $902.6M | +5.7% |
| Capital Expenditures | $28.1M | -38.6% |
| Investing Cash Flow | $286.3M | +393.9% |
| Financing Cash Flow | -$1.22B | -37.3% |
| Free Cash Flow | $874.5M | +8.2% |
| -3.9% |
| Stockholders' Equity |
| -$1.96B |
| -23.8% |